Abstract

Background: The only available tuberculosis (TB) vaccine, Bacillus Calmette-Guérin(BCG), has variable efficacy. New vaccines are therefore urgently needed. Why BCG fails is incompletely understood, and the tools used for early assessment of new vaccine candidates do not account for BCG variability. Taking correlates of risk of TB disease observed in human studies and back-translating them into mice to create models of BCG variability should allow novel vaccine candidates to be tested early in animal models that are more representative of the human populations most at risk. Furthermore, this could help to elucidate the immunological mechanisms leading to BCG failure. We have chosen the monocyte to lymphocyte (ML) ratio as a correlate of risk of TB disease and have back-translated this into a mouse model. Methods: Four commercially available, inbred mouse strains were chosen. We investigated their baseline ML ratio by flow cytometry; extent of BCG-mediated protection from Mtb infection by experimental challenge; vaccine-induced interferon gamma (IFNγ) response by ELISPOT assay; and tissue distribution of BCG by plating tissue homogenates. Results: The ML ratio varied significantly between A/J, DBA/2, C57Bl/6 and 129S2 mice. A/J mice showed the highest BCG-mediated protection and lowest ML ratio, while 129S2 mice showed the lowest protection and higher ML ratio. We also found that A/J mice had a lower antigen specific IFNγ response than 129S2 mice. BCG tissue distribution appeared higher in A/J mice, although this was not statistically significant. Conclusions: These results suggest that the ML ratio has an impact on BCG-mediated protection in mice, in alignment with observations from clinical studies. A/J and 129S2 mice may therefore be useful models of BCG vaccine variability for early TB vaccine testing. We speculate that failure of BCG to protect from TB disease is linked to poor tissue distribution in a ML high immune environment.

Highlights

  • Tuberculosis (TB), caused by Mycobacterium tuberculosis (Mtb) is the leading cause of death from a single infectious agent

  • While Bacillus Calmette-Guérin (BCG) works in some populations and protects children from pulmonary and extra-pulmonary disease, new vaccines are urgently needed for the populations where BCG fails to protect, such as adolescents and adults in endemic areas[1,2]

  • In order to allow early vaccine testing in a model that better represents the populations most at risk of TB disease, we have taken a correlate of risk observed in human studies and back-translated it into a mouse model

Read more

Summary

Introduction

Tuberculosis (TB), caused by Mycobacterium tuberculosis (Mtb) is the leading cause of death from a single infectious agent. Taking correlates of risk of TB disease observed in human studies and back-translating them into mice to create models of BCG variability should allow novel vaccine candidates to be tested early in animal models that are more representative of the human populations most at risk. This could help to elucidate the immunological mechanisms leading to BCG failure. Methods: Four commercially available, inbred mouse strains were chosen We investigated their baseline ML ratio by flow cytometry; extent of BCG-mediated protection from Mtb infection by experimental challenge; vaccine-induced interferon gamma (IFNγ) response by ELISPOT assay; and tissue distribution of BCG by plating tissue homogenates. Conclusions: These results suggest that the ML ratio has an impact version 2

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call